Lantern Pharma Inc Equity-NMS: LTRN

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$3.6
Open :$3.72
Today's high :$3.89
Today's low :$3.48
52W low :$2.79
52W high :$11.99
1Y :-8.3%
5Y :-74.71%
EPS(TTM): :-1.78
Shares O/S :10.78 M
Market cap :40.55 M

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Lantern Pharma Inc $3.76 +0.01% - 40.55M

Frequently Asked Questions

What is the share price of Lantern Pharma Inc today?

Lantern Pharma Inc (LTRN) share price as of January 21, 2025, is $3.76. If you are investing from India, you can always check the valuation in the INR before investing.

About Lantern Pharma Inc

Lantern Pharma Inc. is an artificial intelligence (AI) company. The Company is developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning (ML) platform with multiple clinical-stage drug programs. Its proprietary AI and machine learning (ML) platform, RADR, leverages over 60 billion oncology-focused data points and a library of over 200 advanced ML algorithms to help solve problems in oncology drug development. It is engaged in the development of its pipeline of therapies that span multiple cancer indications, including both solid tumors and blood cancers and an antibody drug conjugate (ADC) program. It has active clinical programs for its three lead small molecule drug candidates: LP-300, LP-184, and LP-284. These programs are focused on multiple cancer indications, including both solid tumors and blood cancers. It is also focused on the clinical execution of its therapies for CNS and brain cancers through Starlight Therapeutics Inc.